Elevated blood β-2 microglobulin is associated with tumor monosomy-3 in patients with primary uveal melanoma.

Abstract

Prognostic blood biomarkers for patients with uveal melanoma have not been identified. Tumor monosomy-3 is strongly associated with the development of metastatic disease. Tumor expression of human leukocyte antigen class I molecules and insulin-like growth factor (IGF)-1 receptor has also been associated with the development of metastatic disease. The… (More)
DOI: 10.1097/CMR.0b013e32835b7154

Topics

Cite this paper

@article{Triozzi2013ElevatedB, title={Elevated blood β-2 microglobulin is associated with tumor monosomy-3 in patients with primary uveal melanoma.}, author={Pierre L Triozzi and Paul J. Elson and Wayne A. Aldrich and Susan Achberger and Raymond R. Tubbs and Charles V Biscotti and Arun Singh}, journal={Melanoma research}, year={2013}, volume={23 1}, pages={1-7} }